Article
27 Jul 2026
China Compliance Update: Anti-Corruption — Summer 2026
AUTHORS CONTENT
Article
17 Jul 2026
Global Anti-Corruption Insights: Summer 2026
Article
08 Jul 2026
China Imposes Export Control And Government Procurement Restrictions On Designated U.S. Companies
Article
24 Jun 2026
China Finalizes Regulations For Pharmaceutical Sales Representatives
Article
17 Jun 2026
National Security Controls And The Life Sciences Sector: BIOSECURE Act, Section 1260H, And COINS Act Developments
Article
06 May 2026
China Compliance Update: Life Sciences — Spring 2026
Article
23 Apr 2026
China Compliance Update: Anti-Corruption — Spring 2026
Article
01 Apr 2026
China Compliance Update: Life Sciences — Spring 2026
Article
19 Mar 2026
Streamlined And Sponsor-Friendly: What China's Amended Drug Regulations Mean For Pharma Companies
Article
11 Mar 2026
China Life Sciences: 2025 Year In Review
Article
11 Mar 2026
China Anti-Corruption: 2025 Year In Review
Article
18 Feb 2026
China Data Privacy And Cybersecurity: 2025 Year In Review
Article
06 Feb 2026
Chinese Regulators Publish New Model Cases On Network Data Security Protection
Article
22 Jan 2026
Global Anti-Corruption Insights: Winter 2026
Article
15 Jan 2026
Recent Enforcement Cases In China Life Sciences Compliance
Article
14 Jan 2026
China Compliance Update — December 2025
Article
13 Jan 2026
China Announces Annual Filing Requirement For Audits Of The Processing Of Minors' Personal Information
Article
21 Nov 2025
China Issues Further Clarifications On Cross-Border Data Transfer Rules
Article
19 Nov 2025
China Life Sciences Compliance Update: Insurance Fraud Enforcement Campaign And New Ethical Code For HCPs
Article
18 Nov 2025
China Clarifies Requirements On Personal Information Protection Certification
